Central and Eastern Europe OTC Drugs Industry Outlook to 2017- Expanding Access to Distribution Channels to Lead Sales Growth: Ken Research
15 Jan, 2014, 14:00 GMT
NEW DELHI, January 15, 2014 /PRNewswire/ --
- Cold and Cough remedies has conventionally remained the leading segment of the industry with a value share of 24.9% of the total sales as of 2012
- The vitamins and mineral supplements sales value have increased predominantly over the years from USD 873.9 million in 2006 to USD 1,091.9 million in 2012
- Slovakia has emerged as the fastest growing market for OTC drugs in the region during this period by recording a CAGR of 13.9% from 2006-2012
Ken Research has announced its report "Central and Eastern Europe OTC Drugs Industry Outlook to 2017- Expanding Access to Distribution Channels to Lead Sales Growth", the practice of treating ailments with non-prescription medicines has evolved as a common system across the world. With burgeoning wealth and increasing awareness of the advantages of good healthcare and healthier lifestyles, emerging markets across the globe such as that of Central and Eastern Europe, Latin America and Asia-Pacific countries are turning out to be significant markets for pharmaceutical drugs. With the growing popularity of over the counter medicines, the availability of such medicines has been vastly expanded across Central and Eastern part of the European region over the years
Ukraine and Bulgaria will be the most rapidly developing markets for OTC medications in Central and Eastern Europe region in the near term. The market in Russia is anticipated to be the largest contributor to the region's market. Ukraine can be prospected as the most promising OTC drugs market in the Central and Eastern Europe region in the near term. The market in Poland however is expected to maintain a moderate growth rate in the next five years with its market rising at a rate of 12.9% from 2012-2017. Hungary and Slovakia are also expected to maintain stable position in Central and Eastern Europe market for OTC medications in the future years by accounting for nearly 3% and 3.5% share respectively by 2017.
Cold and Cough remedies have conventionally remained the leading segment of the industry. Digestives are considered as one of the prime segments of the industry. Overall, the market for OTC digestives in the Central and Eastern European region has grown at a pace of 6.8% over the period 2006-2012.
Key Topics Covered:
- Central and Eastern Europe OTC Drugs Market
- Market Size
- Market Segmentation by Products
- By Cold & Cough
- By Digestives
- Analgesics/ Pain Killers
- Skin Products
- Vitamins and Minerals
- Market Segmentation by Geography
- Slovakia
- Bulgaria
- Russia
- Romania
- Czech Republic
- Poland
- Ukraine
- Hungary
- Trends and Developments
- Future Outlook & Projections
- Russia OTC Drugs Market
- Market Size
- Market Segmentation
- Trends and Developments
- Market Share
- Pharmstandard
- Sanofi Aventis
- Sandoz Group
- Bayer
- Novartis
- Future Outlook and Projections
- Poland OTC Drugs Market
- Market Size
- Market Segmentation
- Market Share
- USP Zdrowie
- Aflofarm
- GSK consumer healthcare
- Bayer
- Roche
- Future Outlook and Projections
4. Ukraine OTC Drugs Market
- Market Size
- Market Segmentation
- Trends and Developments
- Market Share
- Novartis
- Farmak JSC, Kiev
- Menarini Group
- Bayer Healthcare
- Sanofi - Aventis Group
- Future Outlook and Projections
5. Czech Republic OTC Drugs Market
- Market Size
- Market Segmentation
- Trends and Developments
- Market Share
- Competitive Landscape
- Future Outlook and Projections
6. Romania OTC Drugs Market
- Market Size
- Market Segmentation
- Trends & Developments
- Future Outlook and Projections
7. Snapshots of other countries covered
- Hungary
- Slovakia
- Bulgaria
Browse full report:
Similar Reportsin Healthcare Industry:
China Osteoporosis Market Outlook to 2017 - Traditional Chinese Medicine to Steer the Growth
India Hearing Impairment Market Outlook to 2018 - Upsurging Demand for Hearing Care Devices
India Oral Care Industry Outlook to 2018 - Driven by Premiumization of Toothpaste and Mouthwashes
Contact:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249
SOURCE Ken Research